sunitinib taro 25 mg
taro international ltd, israel - sunitinib - hard capsule - sunitinib 25 mg - sunitinib - sunitinib taro is indicated for:• treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • treatment of advanced renal cell carcinoma.• treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
sunitinib taro 37.5 mg
taro international ltd, israel - sunitinib - hard capsule - sunitinib 37.5 mg - sunitinib - sunitinib taro is indicated for:• treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • treatment of advanced renal cell carcinoma.• treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
sunitinib taro 50 mg
taro international ltd, israel - sunitinib - hard capsule - sunitinib 50 mg - sunitinib - sunitinib taro is indicated for:• treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate. • treatment of advanced renal cell carcinoma.• treatment of unresectable or metastatic, well differentiated pancreatic neuroendocrine tumours (pnet) with disease progression.
sunitinib krka 12,5 mg hard caps.
krka d.d. novo mesto d.d. - sunitinib malate 16,71 mg - eq. sunitinib 12,5 mg - capsule, hard - 12,5 mg - sunitinib malate 16.71 mg - sunitinib
sunitinib krka 25 mg hard caps.
krka d.d. novo mesto d.d. - sunitinib malate 33,41 mg - eq. sunitinib 25 mg - capsule, hard - 25 mg - sunitinib malate 33.41 mg - sunitinib
sunitinib krka 50 mg hard caps.
krka d.d. novo mesto d.d. - sunitinib malate 66,83 mg - eq. sunitinib 50 mg - capsule, hard - 50 mg - sunitinib malate 66.83 mg - sunitinib
sunitinib pharmacare 12.5 mg hard capsules
pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 12.5 mg - antineoplastic agents
sunitinib pharmacare 25 mg hard capsules
pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 25 mg - antineoplastic agents
sunitinib pharmacare 37.5 mg hard capsules
pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 37.5 mg - antineoplastic agents
sunitinib pharmacare 50 mg hard capsules
pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 50 mg - antineoplastic agents